Cochrane Renal Group

Registered Cochrane Renal Titles

The following renal titles are 'works in progress' and have been registered with the Cochrane Renal Group.

Registered titles

  • Adjunctive medical expulsive therapy for renal and ureteral stone fragments immediately following shock wave lithotripsy. Sani Usman Alhassan (Nigeria)
  • Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for preserving residual kidney function in peritoneal dialysis patients. Ling Zhang (China)
  • Antibiotic prophylaxis for transurethral endo-urological procedures. Basim S Alsaywid (Australia)
  • Antihypertensive agents in children with chronic kidney disease. Amrit Kaur (UK)
  • Calcium channel blockers as medical expulsive therapy for ureteric stones. Chris Williams (UK)
  • Citrate salts for preventing and treating kidney stones. Chandra S Biyani (UK)
  • Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease. Kushma Nand (Australia)
  • Conventional dissection versus plastic device circumcision for treating phimososis in pediatric patients. Juliana Santos (Brazil)
  • Cyclosporin target values in the immediate post-operative period for kidney transplant recipients. Catherine Cornu (France)
  • Darbepoetin for anaemia in chronic renal failure
  • Dialysate temperature control for haemodialysis
  • Dopamine for acute kidney injury. KeHu Yang (China)
  • Dopamine for preventing early graft dysfunction in kidney transplant recipients Medi Eslani (Iran)
  • Educational interventions for metabolic bone disease in patients with chronic kidney disease. Yue Zhao (China)
  • Glucose lowering therapies for chronic kidney disease and kidney transplantation. Sophia Zoungas (Australia)
  • Glucose targets for preventing diabetic kidney disease and it progression. Salvatore De Cosmo (Italy)
  • Haemodialysis duration and frequency for end-stage kidney disease. Vlado Perkovic (Australia)
  • HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass. Patrick Murray (Ireland)
  • Human albumin infusion for nephrotic syndrome. Zainal Darus (Malaysia)
  • Immunosuppressive induction therapy for lung transplant recipients. Luit Penninga (Denmark)
  • Interventions for preventing intradialytic hypotension in haemodialysis patients. Muralikrishna Gangadharan Komala (Australia)
  • Interventions for pruritus in chronic kidney disease. Timothy J Pianta (Australia)
  • Interventions for chronic kidney disease-associated restless legs syndrome. Sherif Mohamed (UK)
  • Interventions for implementing evidence-based medicine in renal clinical practice. Michelle Irving (Australia)
  • Loop diuretics for patients receiving blood transfusions. Aaron M Tejani (Canada)
  • Maintenance calcineurin inhibitor levels for kidney transplant recipients. Taixiang Wu (China)
  • Nutritional support for adults with end-stage kidney disease on renal replacement therapy
  • Pentoxifylline for chronic kidney disease. Rommel P Bataclan (Philippines)
  • Percutaneous angioplasty or stenting for stenosed but functioning haemodialysis access fistulae and grafts. Sally Anne Turner (UK)
  • Pidotimod for preventing recurrent urinary tract infection. Xiao dong Guo (China)
  • Probiotics for preventing urinary tract infection in people with neuropathic bladder. Bon San B Lee (Australia)
  • Probiotics for treating mutli-resistant organism (MRO) colonisation/infection. Bonsan Lee (Australia)
  • Single versus simultaneous-double paediatric donor organs for adult kidney transplant recipients. Qing Yuan (China)
  • Sodium bicarbonate supplements for acute kidney injury. Jonathan Hewitt (UK)
  • Supine versus prone positioning for percutaneous nephrolithotripsy (PNL). Liang Ren Liu (China)
  • Support interventions for caregivers of patients with chronic kidney disease. Allison Tong (Australia)
  • Target of rapamycin inhibitors (TORi) as maintenance immunosuppression for kidney transplant recipients. Luciana Saturnino (Brazil)
  • Topical corticosteroids for treating phimosis in children. Gladys Moreno (Chile)
  • Treatment for BK virus nephropathy in kidney transplant recipients. Sree Krishna Venuthurupalli (Australia)
  • Tubeless versus standard percutaneous nephrolithotomy for treating kidney stones. Hong Li (China)
  • Uric acid lowering therapies for chronic kidney disease. Anna Sampson (Australia)
  • Vascular access surveillance for patients on haemodialysis. Louise Moist (Canada)
  • Vascular access type for people on chronic haemodialysis.Matthew T James (Canada)

Working for Cochrane renal group

nephrology series

Podcasts
Listen to a podcast of
Cranberries for preventing urinary tract infections


A subscription may be required if accessing outside Australia.

new renal reviews

 

madrid logo

 

Introduction to writing
a Cochrane systematic review:
Sydney workshops 2012
[Details]

 

Are you interested in writing a review?

Contact us for potential review titles!

Help us with our Renal Trials Register

Do you have conference proceedings [books or cd-roms] that you no longer need or could lend to us for hadsearching? If so, email Ruth Mitchell for details

Handsearching

Are you interested in helping us handsearch journals or conference proceedings. To find out more about our handsearching activities, email Ruth Mitchell